Prostate Cancer - Results from #960

Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial May 7, 2024

The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy. May 7, 2024

A Comprehensive Review of the Current State of Robot-assisted Laparoscopic Salvage Prostatectomy. May 7, 2024

Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine Learning. May 7, 2024

Deep learning based automatic segmentation of the Internal Pudendal Artery in definitive radiotherapy treatment planning of localized prostate cancer. May 7, 2024

Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. May 7, 2024

Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial. May 6, 2024

Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going. May 6, 2024

PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI. May 6, 2024

Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. May 6, 2024

The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study. May 6, 2024

Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease. May 6, 2024

Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study. May 6, 2024

Plant-Based Diets and Disease Progression in Men With Prostate Cancer. May 3, 2024

Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database. May 3, 2024

Elective Pelvic Lymph Node Radiation Therapy and the Risk of Death in Patients With Unfavorable-Risk Prostate Cancer: A Postrandomization Analysis. May 3, 2024

Prostate size ≥ 100 g and its association with long-term outcomes of Retzius-sparing robot-assisted radical prostatectomy. May 3, 2024

Suitability of the MP1000 Platform for Robot-assisted Prostatectomy: A Prospective Randomised Controlled Trial. May 3, 2024

Diagnostic Utility of Artificial Intelligence-assisted Transperineal Biopsy Planning in Prostate Cancer Suspected Men: A Prospective Cohort Study. May 2, 2024

Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED). May 2, 2024

Page 49 of 1437